Mitsubishi UFJ Asset Management Co. Ltd. increased its stake in CVS Health Corporation by 11.3%, acquiring an additional 226,997 shares, bringing its total holdings to about 2.24 million shares valued at approximately $151.63 million. CVS Health reported a significant quarterly earnings beat with an EPS of $1.81, exceeding analyst expectations of $1.46, and demonstrated a year-over-year revenue increase of 8.4%. The company announced a quarterly dividend of $0.665 per share, yielding about 4.2%, with a payout ratio of 74.30% as of the latest announcement. Several other hedge funds and institutional investors have also recently made changes to their positions in CVS. Envestnet Asset Management Inc. lifted its stake in shares of CVS Health by 1.0% in the fourth quarter. Envestnet Asset Management Inc. now owns 1,529,714 shares of the pharmacy operator's stock worth $68,669,000 after buying an additional 15,561 shares in the last quarter. FIL Ltd lifted its position in CVS Health by 5.3% during the fourth quarter. FIL Ltd now owns 141,616 shares of the pharmacy operator's stock valued at $6,357,000 after purchasing an additional 7,143 shares during the period. APG Asset Management US Inc. lifted its position in CVS Health by 45.8% during the fourth quarter. APG Asset Management US Inc. now owns 25,996 shares of the pharmacy operator's stock valued at $1,167,000 after purchasing an additional 8,163 shares during the period. Bessemer Group Inc. lifted its position in CVS Health by 0.6% during the fourth quarter. Bessemer Group Inc. now owns 66,617 shares of the pharmacy operator's stock valued at $2,991,000 after purchasing an additional 429 shares during the period. Finally, F M Investments LLC lifted its position in CVS Health by 12.0% during the fourth quarter. F M Investments LLC now owns 28,542 shares of the pharmacy operator's stock valued at $1,281,000 after purchasing an additional 3,062 shares during the period. Institutional investors own 80.66% of the company's stock. Director bought 1,570 shares of the company's stock in a transaction that occurred on Thursday, June 5th. The stock was purchased at an average price of $63.70 per share, for a total transaction of $100,009.00. Following the completion of the transaction, the director owned 12,007 shares in the company, valued at $764,845.90. The trade was a 15.04% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through. Corporate insiders own 1.22% of the company's stock. CVS Health shares traded up $1.91 during midday trading on Friday, reaching $65.49. 6,458,438 shares of the company were exchanged, compared to its average volume of 9,248,730. The company has a current ratio of 0.80, a quick ratio of 0.62 and a debt-to-equity ratio of 0.74. The business's fifty day moving average is $64.68 and its two-hundred day moving average is $64.31. CVS Health Corporation has a one year low of $43.56 and a one year high of $72.51. The stock has a market cap of $83.06 billion, a PE ratio of 18.29, a price-to-earnings-growth ratio of 0.72 and a beta of 0.58. CVS Health ( - ) last issued its earnings results on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share for the quarter, topping analysts' consensus estimates of $1.46 by $0.35. CVS Health had a net margin of 1.17% and a return on equity of 10.51%. The firm had revenue of $98.92 billion during the quarter, compared to analyst estimates of $94.87 billion. During the same quarter in the prior year, the business earned $1.83 earnings per share. CVS Health's revenue for the quarter was up 8.4% on a year-over-year basis. As a group, analysts predict that CVS Health Corporation will post 5.89 earnings per share for the current year. The business also recently announced a quarterly dividend, which was paid on Friday, August 1st. Investors of record on Tuesday, July 22nd were given a dividend of $0.665 per share. The ex-dividend date was Tuesday, July 22nd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.1%. CVS Health's dividend payout ratio is currently 74.30%. Analysts Set New Price Targets CVS has been the topic of a number of research analyst reports. Bernstein Bank lowered their price objective on shares of CVS Health from $78.00 to $72.00 and set a 'market perform' rating on the stock in a research report on Wednesday, July 16th. Royal Bank Of Canada increased their price objective on shares of CVS Health from $74.00 to $81.00 and gave the company an 'outperform' rating in a research report on Monday, May 5th. Barclays increased their price objective on shares of CVS Health from $79.00 to $80.00 and gave the company an 'overweight' rating in a research report on Friday, August 1st. Wells Fargo & Company restated an 'overweight' rating and set a $84.00 price objective (up previously from $76.00) on shares of CVS Health in a research report on Tuesday, May 6th. Finally, raised shares of CVS Health from a 'hold' rating to a 'buy' rating in a report on Friday, May 9th. Three research analysts have rated the stock with a hold rating, eighteen have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of 'Moderate Buy' and an average price target of $75.11. CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Mitsubishi UFJ Asset Management Co. Ltd. Buys 226,997 Shares of CVS Health Corporation (NYSE:CVS)

Mitsubishi UFJ Asset Management Co. Ltd. increased its stake in CVS Health Corporation by 11.3%, acquiring 226,997 shares, bringing total holdings to approximately 2.24 million shares valued at $151.63 million. CVS Health reported a quarterly earnings beat with an EPS of $1.81, exceeding analyst expectations of $1.46, and posted an 8.4% year-over-year revenue increase. The company announced a quarterly dividend of $0.665 per share, yielding about 4.2% with a payout ratio of 74.30%. Other institutional investors, including Envestnet, FIL Ltd, APG Asset Management US Inc., Bessemer Group Inc., and F M Investments LLC, also increased their positions in CVS Health during the fourth quarter. Institutional investors collectively own 80.66% of the company’s stock, while corporate insiders own 1.22%. CVS Health shares rose to $65.49 during midday trading, with a market cap of $83.06 billion, a PE ratio of 18.29, and a one-year price range of $43.56 to $72.51. Analysts have revised price targets, with Barclays, Royal Bank of Canada, and Wells Fargo increasing their ratings and price objectives, while Bernstein lowered its target. The company operates in health care benefits, health services, and pharmacy & consumer wellness segments.